CD38-RyR2 axis-mediated signaling impedes CD8+ T cell response to anti-PD1 therapy in cancer

dc.contributor.author	Gautam, Anupam
dc.date.accessioned	2025-02-28T08:19:37Z
dc.date.available	2025-02-28T08:19:37Z
dc.date.issued	2024
dc.identifier.issn	0027-8424
dc.identifier.uri	http://hdl.handle.net/10900/162591
dc.language.iso	en	en
dc.publisher	Washington : Natl Acad Sciences	de_DE
dc.relation.uri	http://dx.doi.org/10.1073/pnas.2315989121
dc.subject.ddc	500	de_DE
dc.title	CD38-RyR2 axis-mediated signaling impedes CD8+ T cell response to anti-PD1 therapy in cancer	de_DE
dc.type	Article	de_DE
utue.quellen.id	20241001000000_02400
utue.personen.roh	Kara, Anwesha
utue.personen.roh	Ghosha, Puspendu
utue.personen.roh	Gautamc, Anupam
utue.personen.roh	Chowdhurya, Snehanshu
utue.personen.roh	Basaka, Debashree
utue.personen.roh	Sarkara, Ishita
utue.personen.roh	Bhoumika, Arpita
utue.personen.roh	Barmanb, Shubhrajit
utue.personen.roh	Chakrabortyf, Paramita
utue.personen.roh	Mukhopadhyayg, Asima
utue.personen.roh	Mehrotraf, Shikhar
utue.personen.roh	Ganesane, Senthil Kumar
utue.personen.roh	Paulh, Sandip
utue.personen.roh	Chatterjeea, Shilpak
dcterms.isPartOf.ZSTitelID	Proceedings of The National Academy of Sciences of The United States of America	de_DE
dcterms.isPartOf.ZS-Issue	11	de_DE
dcterms.isPartOf.ZS-Volume	121	de_DE
utue.fakultaet	04 Medizinische Fakultät
utue.fakultaet	07 Mathematisch-Naturwissenschaftliche Fakultät
utue.fakultaet	Sonstige